Phase-Ib dose-finding and pharmacokinetic trial of metformin combined with nivolumab for refractory/recurrent solid tumors
Authors
- Heiichiro Udono (ORCID: https://orcid.org/0000-0002-9407-2296)
- Akinori Asagi
- Toshio Kubo (ORCID: https://orcid.org/0000-0002-2545-3052)
- Katsuyuki Hotta (ORCID: https://orcid.org/0000-0002-0112-0843)
- Hironari Kato (ORCID: https://orcid.org/0000-0003-1120-292X)
- Katsuyuki Kiura (ORCID: https://orcid.org/0000-0002-9172-9379)
- Toshiyuki Kozuki (ORCID: https://orcid.org/0000-0001-8432-8975)
- Michihiro Yoshida (ORCID: https://orcid.org/0000-0002-4167-2781)
- Shigeru Horiguchi
Institutions
- Okayama University (JP)
- Okayama University Hospital (JP)
- Shikoku Cancer Center (JP)
Publication Details
- Journal
- International Journal of Clinical Oncology
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1007/s10147-025-02786-2
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Okayama University
- Kansai Medical University
- Ono Pharmaceutical